Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

Tommaso Susini,1 Barbara Berti,1 Carlo Carriero,1 Ketty Tavella,2 Jacopo Nori,3 Ermanno Vanzi,3 Cecilia Molino,1 Mariarosaria Di Tommaso,1 Marco Santini,1 Valeria Saladino,4 Simonetta Bianchi4 1Department of Health Science, Gynecology Section, 2Department of Health Science, Chemotherapy Section, Un...

Full description

Bibliographic Details
Main Authors: Susini T, Berti B, Carriero C, Tavella K, Nori J, Vanzi E, Molino C, Di Tommaso M, Santini M, Saladino V, Bianchi S
Format: Article
Language:English
Published: Dove Medical Press 2014-11-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/topoisomerase-ii-alpha-and-tle3-as-predictive-markers-of-response-to-a-peer-reviewed-article-OTT

Internet

http://www.dovepress.com/topoisomerase-ii-alpha-and-tle3-as-predictive-markers-of-response-to-a-peer-reviewed-article-OTT

Similar Items